Despite political and social unrest percolating in parts of the region, the Middle East pharmaceutical market is experiencing strong growth. With government policies and investments supporting the growing healthcare infrastructure, multinational companies are seeing keen opportunities to tap into the region’s economic potential. Although the strong growth ensures an attractive market, characteristics such as rigid price controls, low per capita spending on health in some regions, and the GCC price harmonisation process can make navigating the landscape challenging.
Leveraging interviews with industry professionals, physicians, and payors, in-depth secondary research, and regional market access expertise, Market Access in the Middle East: How Pricing Reform Impacts Pharmaceutical Uptake Strategies provides the insights and analysis needed to fully capitalize on this growing market.
Answering your key questions